Home/Filings/4/0000950170-25-097269
4//SEC Filing

White Marvin L 4

Accession 0000950170-25-097269

CIK 0001671584other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 4:36 PM ET

Size

6.8 KB

Accession

0000950170-25-097269

Insider Transaction Report

Form 4
Period: 2025-07-17
White Marvin L
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-07-17+1012 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-07-171020 total
    Common Stock (30 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On July 17, 2024, the reporting person was granted 22,325 (30 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.

Documents

1 file

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeother

Related Parties

1
  • filerCIK 0001493324

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:36 PM ET
Size
6.8 KB